Effects of CI-914 in congestive heart failure due to coronary artery disease or idiopathic cardiomyopathy

The American Journal of Cardiology
S TerrisB Pitt

Abstract

The hemodynamic effects of CI-914, a phosphodiesterase inhibitor, were studied in 12 patients with left ventricular (LV) dysfunction who were undergoing diagnostic cardiac catheterization. CI-914 was infused intravenously at a rate of 0.8 to 7.0 micrograms/kg/min for 30 to 60 minutes; hemodynamic values were measured every 10 minutes. No effect was seen in the patient receiving 0.8 microgram/kg/min. At infusion rates of 1.2 to 2.4 micrograms/kg/min, cardiac index increased by 14% (p less than 0.025). At infusion rates of 4.5 to 7.0 micrograms/kg/min, cardiac index increased by 21% (n = 8, difference not significant [NS]). Among 4 patients (group B) with an initial pulmonary artery wedge pressure greater than 20 mm Hg and cardiac index less than 2.5 liters/min/m2, cardiac index increased by 50% (p less than 0.001); it did not change among the 4 patients with an initial pulmonary artery wedge pressure of less than 20 mm Hg and cardiac index of more than 2.5 liters/min/m2 (group A). Although systemic vascular resistance decreased in all 8 patients by 26% (p less than 0.01), the reduction was greater in group B (33%, p less than 0.01) than in group A (16%, NS). Peak +dP/dt increased in all 8 patients by 13% (p less than 0.01). Mean...Continue Reading

References

Mar 16, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·M Korth
Feb 1, 1979·Circulation Research·G I Drummond, D L Severson
Oct 1, 1979·Clinical Cardiology·D BallerG Hellige
Sep 1, 1976·The Journal of Clinical Investigation·J L WeissM L Weisfeldt
Feb 1, 1986·The American Journal of Cardiology·S M JafriS Goldstein
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Aug 1, 1984·Journal of the American College of Cardiology·H Scholz
Mar 1, 1984·British Journal of Clinical Pharmacology·P T WilmshurstM M Webb-Peploe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.